– Strengthening partnerships with pharmaceutical companies to bring an unprecedented medical experience Japan And the US to build a medical information platform –
Tokyo And Singapore, August 22, 2022 /PRNewswire/ — Ubie, Inc., a healthcare AI startup, has announced its mission to “develop healthcare guidance for everyone.” 26.2 million dollars (*1) Series C funding in Round 1. New investors in the round include Norinchukin Capital Co., Ltd., Venture Capital Ltd. (a wholly-owned subsidiary of Neck Capital Solutions Ltd.), Dai-ichi Life Insurance Company, Ltd. and Egg FORWARD, Inc., with existing investors Suzuki. CO., LTD. As of today, Ubie is up. 59.8 million dollars (*2)
Ubie is one of the few startups with a medical data platform that has a direct relationship with patients and medical facilities. Using AI as its core technology, Ubie offers two services that focus on “medical inquiry” as a gateway to healthcare.
The “AI-powered symptom checker” offered to patients asks about 20 questions about their symptoms to find related diseases and provide more detailed actionable health information. Since its launch, it has been trusted by 5 million monthly users worldwide Japan and the US
Ubie offers “AI-powered patient intake” that streamlines the medical interview process for medical facilities. This service is based on a database of nearly 50,000 medical articles worldwide, created by more than 50 active physicians. The service has been introduced to more than 1,000 medical facilities worldwide and is improving the operational efficiency of the facilities.
Ubie will aim to bring a new medical experience. Japan and connecting patients, medical facilities and pharmaceutical companies through a medical information platform that the US is building to address the following medical issues;
– Ensuring patients visit the right medical facility at the right time,
– Ensuring that physicians have access to relevant and up-to-date information on diseases and rare diseases without exception, and,
– Ensuring that pharmaceutical companies continue to provide patients with relevant information and scientific findings related to their conditions.
Series C funding is used to fuel business growth Japan and the US to build a medical information platform that connects patients, medical facilities and pharmaceutical companies.
Ubie Co-Founder and CEO Yoshinori AbeMD, said: “Not only in JapanBut in other countries, the current health care system is suffering from various losses due to the sharing of information held by patients, medical facilities and pharmaceutical companies. This fundraising aims to accelerate collaboration with pharmaceutical companies and create an unprecedented consumer-centric medical experience using the Ubie data platform. Ubi has business with more than 20 major pharmaceutical companies in Japan and other countries, and this brings Ubi closer to realizing its mission of ‘developing healthcare guidelines for everyone’. Japan and America.”
Notes:
(*1) 26.2 million dollars = JPY 3.5 billion (such as August 12, 2022)
(*2) 59.8 million dollars = JPY 7.98 billion (same as above, same as above, same as above)
About Ubi
UB is a Japanese health technology startup founded in 2017 by a medical doctor and engineer. Using AI as its core technology, the company develops and delivers an AI-powered patient questionnaire that guides patients from symptoms to appropriate medical care and improves operational efficiency. In the medical field. Ubi is promoting a society where everyone can get the medical care they deserve.
For more information, please visit: http://company.ubiehealth.com
AI Powered Signal Validator: https://ubiehealth.com
(Japanese version: https://ubie.app/ )
Source Ubie, Inc.
